InvestorsHub Logo
Followers 44
Posts 4950
Boards Moderated 0
Alias Born 04/30/2005

Re: Hoskuld post# 440152

Sunday, 11/26/2023 2:20:28 PM

Sunday, November 26, 2023 2:20:28 PM

Post# of 470015
I did a quick search and found the company below received a rejection letter from the FDA...but they never informed their shareholders that they applied for a New Drug application. [If you want more examples, you'll have to do your own research]

******************************************************************************************************

Denali Therapeutics Announces The Co. Received A Formal Clinical Hold Letter And Is Moving Forward To Address The FDA's Observations Related To The Preclinical Toxicology Assessment And To Provide The Information Requested To Initiate Clinical Studies
February 14, 2022

As previously announced, Denali Therapeutics Inc. (“Denali”) was informed on January 12, 2022, via e-mail communication from the U.S. Food and Drug Administration (FDA) that the DNL919 Investigational New Drug (IND) application to begin clinical testing was placed on clinical hold. Denali has now received a formal clinical hold letter and is moving forward to address the FDA’s observations related to the preclinical toxicology assessment and to provide the information requested to initiate clinical studies, including proposed changes to the clinical trial protocol, the informed consent form, and the investigator brochure. Denali intends to provide an update once a clear path forward has been established.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News